Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes
Cancers · 10.04.2026 · 18 (8) · 1214
DOI: 10.3390/cancers18081214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 10.04.2026. Verfasst von Prakash Gangadaran und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Traditional cancer therapies such as surgery, chemotherapy, and antibody-based treatments often face significant barriers, including systemic toxicity, a lack of selectivity, and the emergence of drug resistance. These issues demand innovative and targeted solutions. Peptide-based therapeutics have gained prominence for their ability to disrupt cancer pathways and facilitate targeted drug delivery, offering structural flexibility, precise targeting, and low immunogenicity with minimal effects on healthy tissues. Concurrently, aptamers, which are structured nucleic acid molecules capable of high-affinity molecular recognition, are being developed as both direct therapeutic agents and as targeting ligands for the improved delivery of anticancer drugs. Combining peptide and aptamer technologies with engineered exosomes provides a modular drug delivery system that enhances targeting specificity, stability, and the ability to cross complex biological barriers such as the blood–brain barrier. The emergence of peptide-decorated, aptamer-decorated exosomes represents a new frontier in precision oncology, promising highly selective, biocompatible, and tunable cancer therapies. Further advances are required to overcome challenges in pharmacokinetics, scalable production, and regulatory compliance, but ongoing bioengineering and nanotechnology research continues to accelerate the translation of these innovative strategies toward improved cancer diagnostics and treatment outcomes. This review discusses the synergistic integration of peptides and aptamers with exosome-based delivery systems, highlighting their current applications and future possibilities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Cardiovascular Research Institute, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Genetic Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603203, India.
- BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela 769008, India.
- Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
ORCID-Profile: Prakash Gangadaran, Sanjana Dhayalan, Ramya Lakshmi Rajendran, Vasanth Kanth Thasma Loganathbabu, Chae Moon Hong, Byeong-Cheol Ahn
Förderung
- National Research Foundation of Korea
Zitieren
APA
Gangadaran, P., Kumar, A. S., Kumaran, K., Prakash, K., Dhayalan, S., Rajendran, R. L., Loganathbabu, V. K. T., Balaji, J., Baskaran, R., Arun, R., Karthikeyan, V., Biswas, S., Hong, C. M., ArulJothi, K. N., & Ahn, B. C. (2026). Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. Cancers, 18(8), 1214. https://doi.org/10.3390/cancers18081214
Vancouver
Gangadaran P, Kumar AS, Kumaran K, Prakash K, Dhayalan S, Rajendran RL, et al. Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. Cancers. 2026;18(8):1214. doi:10.3390/cancers18081214
BibTeX
@article{Gangadaran2026,
author = {Gangadaran, Prakash and Kumar, Aswini Suresh and Kumaran, Kasinathan and Prakash, Kruthika and Dhayalan, Sanjana and Rajendran, Ramya Lakshmi and Loganathbabu, Vasanth Kanth Thasma and Balaji, Janani and Baskaran, Radhika and Arun, Raksa and Karthikeyan, Vanshikaa and Biswas, Sreyee and Hong, Chae Moon and ArulJothi, Kandasamy Nagarajan and Ahn, Byeong-Cheol},
title = {Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes},
journal = {Cancers},
year = {2026},
volume = {18},
number = {8},
pages = {1214},
doi = {10.3390/cancers18081214}
}
EUVIMED